Session Tracks

This track focuses on the unique dermatological conditions affecting neonates, including neonatal nutrition and its impact on skin health. Discussions will include advancements in the management of bilirubin encephalopathy and neonatal polycythemia.

This session will explore the genetic basis of various genodermatoses and their implications for pediatric patients. Emphasis will be placed on novel therapeutic strategies and the role of genetic counseling.

This track will delve into the pathophysiology of acne in children and adolescents, examining the psychosocial impacts and treatment modalities. Participants will discuss evidence-based approaches to managing this common condition.

This session will address the clinical management of warts and vitiligo in pediatric patients, highlighting recent advancements in treatment options. The discussion will also cover the psychosocial implications of these conditions.

This track will focus on the diagnosis and management of bacterial skin infections in pediatric populations. Participants will explore emerging trends in antibiotic resistance and its impact on treatment outcomes.

This session will examine the epidemiology of fungal skin infections in children and the latest therapeutic strategies. Discussions will include the challenges of diagnosis and the role of antifungal agents.

This track will explore the various viral skin infections affecting pediatric patients, including their clinical manifestations and management strategies. Participants will discuss the implications of vaccination and public health measures.

This session will highlight recent advancements in the treatment of dermatitis in children, focusing on the efficacy of new therapeutic agents. The discussion will also cover the importance of individualized treatment plans.

This track will delve into the immunological aspects of skin infections in children, examining how immune responses influence disease outcomes. Participants will discuss the implications for vaccine development and therapeutic interventions.

This session will address the growing concern of microbial resistance in pediatric dermatology, focusing on its impact on treatment efficacy. Discussions will include strategies for prevention and management of resistant infections.

This track will focus on the increasing incidence of melanoma in pediatric populations, emphasizing the importance of early detection and intervention. Participants will explore current treatment protocols and future directions in research.